Search Results for:

The Bankruptcy, Restructuring & Workouts Considerations in the Age of COVID-19 Webcast will provide an overview of strategic alternatives available to potentially distressed Germany-based companies with business interest or operations in the U.S.
No Date

COVID-19 Disruption in Life Sciences: Tax, Trade and Value Chain Implications webcast will provide an overview of the tax and trade issues relating to supply chain restructuring that Life Sciences companies are navigating due to the disruption.
No Date

This webcast discussed the new U.S. law tax provisions available to help mitigate the impact of COVID-19 and the initial, potential implications for businesses.
No Date

This webcast will provide an overview of the tax and trade issues relating to supply chain restructuring that consumer and retail companies are navigating due to the disruption.
No Date

The COVID-19 pandemic has created multiple challenges for international businesses. What does it mean to multinational companies with interest or operations in the United Kingdom? What are the strategies and available funding schemes for businesses?
No Date

Access past issues, blogs, and podcasts from the Privately Speaking series.
No Date

The German M&A Opportunities Post-COVID-19 Webcast will provide an overview of future investment opportunities in Germany and how COVID-19 may potentially change future dealmaking.
No Date

KPMG’s Investing in Europe Webcast will provide participants with an understanding of the German M&A outlook post COVID-19.
No Date

This article, reproduced with the permission of the Association of Government Accountants, focuses on the movement to intelligent automation and its impact on all facets of financial management, program management, and auditing.
No Date

How can data and analytics be used to make predictions about student engagement and student retention in higher education?
No Date

This article, reproduced with the permission of the Association of Government Accountants, discusses how federal agencies can restore public trust in government by implementing a five-dimension program integrity framework that fosters strong program performance.
No Date

This white paper elaborates on the broad meaning of program integrity in the context of federal healthcare.
No Date

The key to managing risks is largely cultural and will not be fixed if agencies only implement The Playbook: Enterprise Risk Management for the U.S. Government or additional controls.
No Date

Learn more about correlation of ERM to mission achievement for federal leaders.
No Date

As momentum for AI grows, government is faced with the daunting task of moving proofs of concept into production.
No Date